Medications and Clinical Trials
1. The following material is prepared for informational purposes only and should in no way be considered medical advice.
2. The mention of trade names, publications, commercial organizations, specific therapies or health care providers in no way constitutes a recommendation or endorsement.
3. Readers are encouraged to seek independent advice of qualified professionals.
Keppra now approved in oral solution:
July 17, 2003- The U.S. Food and Drug Admonistration (FDA) has approved grape-flavored, dye-free Keppra (levetiracetam) oral solution (100 mg/mL), providing a new option for patients with epilepsy who prefer a liquid or cannot swallow tablets. For more information, visit keppra.com.
ClinicalTrials.gov is a service of the U.S. National Institutes of Health and was developed by the Library of Medicine.
Novartis Pharmaceuticals Corporation has just launched a large-scale clinical trial for children suffering from epilepsy. Patients are needed for this clinical trial of an investigational treatment for epilepsy in children under 4 years old: http://etrials.novartis.com/patients/epilepsy.jsp?bmrepl000045
The NINDS has released the following finding:
Study Reveals Patterns of Gene Activity in the Mouse Nervous System